UBS Group’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111K | Buy |
75,150
+73,063
| +3,501% | +$108K | ﹤0.01% | 5885 |
|
|
2025
Q1 | $5.34K | Sell |
2,087
-16,091
| -89% | -$41.2K | ﹤0.01% | 7694 |
|
|
2024
Q4 | $34.2K | Buy |
18,178
+17,886
| +6,125% | +$33.6K | ﹤0.01% | 6304 |
|
|
2024
Q3 | $298 | Sell |
292
-15
| -5% | -$15 | ﹤0.01% | 7796 |
|
|
2024
Q2 | $359 | Sell |
307
-67,649
| -100% | -$79.1K | ﹤0.01% | 7790 |
|
|
2024
Q1 | $85.6K | Sell |
67,956
-6,762
| -9% | -$8.52K | ﹤0.01% | 5135 |
|
|
2023
Q4 | $133K | Buy |
74,718
+37,658
| +102% | +$67K | ﹤0.01% | 4837 |
|
|
2023
Q3 | $61.5K | Sell |
37,060
-14,980
| -29% | -$24.9K | ﹤0.01% | 5044 |
|
|
2023
Q2 | $104K | Buy |
52,040
+47,349
| +1,009% | +$94.7K | ﹤0.01% | 4937 |
|
|
2023
Q1 | $9.85K | Buy |
4,691
+4,571
| +3,809% | +$9.6K | ﹤0.01% | 6526 |
|
|
2022
Q4 | $164 | Sell |
120
-10,998
| -99% | -$15K | ﹤0.01% | 9139 |
|
|
2022
Q3 | $11K | Buy |
11,118
+10,998
| +9,165% | +$10.9K | ﹤0.01% | 7216 |
|
|
2022
Q2 | $0 | Hold |
120
| – | – | ﹤0.01% | 9600 |
|
|
2022
Q1 | $0 | Hold |
120
| – | – | ﹤0.01% | 9499 |
|
|
2021
Q4 | $0 | Sell |
120
-2,194
| -95% | – | ﹤0.01% | 9321 |
|
|
2021
Q3 | $3K | Buy |
2,314
+389
| +20% | +$504 | ﹤0.01% | 7673 |
|
|
2021
Q2 | $3K | Sell |
1,925
-270
| -12% | -$421 | ﹤0.01% | 7719 |
|
|
2021
Q1 | $10K | Buy |
2,195
+998
| +83% | +$4.55K | ﹤0.01% | 6909 |
|
|
2020
Q4 | $5K | Sell |
1,197
-3,315
| -73% | -$13.8K | ﹤0.01% | 6809 |
|
|
2020
Q3 | $17K | Buy |
4,512
+859
| +24% | +$3.24K | ﹤0.01% | 5575 |
|
|
2020
Q2 | $14K | Buy |
3,653
+3,474
| +1,941% | +$13.3K | ﹤0.01% | 5943 |
|
|
2020
Q1 | $0 | Buy |
179
+129
| +258% | – | ﹤0.01% | 7163 |
|
|
2019
Q4 | $0 | Sell |
50
-6,682
| -99% | – | ﹤0.01% | 7142 |
|
|
2019
Q3 | $14K | Sell |
6,732
-13,242
| -66% | -$27.5K | ﹤0.01% | 5989 |
|
|
2019
Q2 | $93K | Buy |
19,974
+4,229
| +27% | +$19.7K | ﹤0.01% | 4583 |
|
|
2019
Q1 | $69K | Sell |
15,745
-113
| -0.7% | -$495 | ﹤0.01% | 4525 |
|
|
2018
Q4 | $49K | Buy |
15,858
+12,419
| +361% | +$38.4K | ﹤0.01% | 5209 |
|
|
2018
Q3 | $25K | Buy |
3,439
+2,379
| +224% | +$17.3K | ﹤0.01% | 5758 |
|
|
2018
Q2 | $4K | Sell |
1,060
-10,098
| -91% | -$38.1K | ﹤0.01% | 6630 |
|
|
2018
Q1 | $60K | Buy |
11,158
+4,231
| +61% | +$22.8K | ﹤0.01% | 4736 |
|
|
2017
Q4 | $46K | Sell |
6,927
-164
| -2% | -$1.09K | ﹤0.01% | 4948 |
|
|
2017
Q3 | $41K | Sell |
7,091
-29,878
| -81% | -$173K | ﹤0.01% | 5048 |
|
|
2017
Q2 | $309K | Buy |
36,969
+36,919
| +73,838% | +$309K | ﹤0.01% | 3650 |
|
|
2017
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 6508 |
|
|
2016
Q4 | $0 | Sell |
50
-868
| -95% | – | ﹤0.01% | 6860 |
|
|
2016
Q3 | $5K | Buy |
918
+365
| +66% | +$1.99K | ﹤0.01% | 6194 |
|
|
2016
Q2 | $3K | Buy |
553
+503
| +1,006% | +$2.73K | ﹤0.01% | 6420 |
|
|
2016
Q1 | $0 | Sell |
50
-30
| -38% | – | ﹤0.01% | 6814 |
|
|
2015
Q4 | $1K | Sell |
80
-289
| -78% | -$3.61K | ﹤0.01% | 6716 |
|
|
2015
Q3 | $4K | Buy |
369
+289
| +361% | +$3.13K | ﹤0.01% | 6378 |
|
|
2015
Q2 | $2K | Sell |
80
-436
| -84% | -$10.9K | ﹤0.01% | 6551 |
|
|
2015
Q1 | $9K | Buy |
516
+351
| +213% | +$6.12K | ﹤0.01% | 5921 |
|
|
2014
Q4 | $3K | Buy |
+165
| New | +$3K | ﹤0.01% | 6510 |
|